Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 119020-03-0 | MDL No. : | MFCD06658394 |
Formula : | C13H18N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NQGRCKNDDGCZPV-UHFFFAOYSA-N |
M.W : | 234.29 | Pubchem ID : | 4712622 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.46 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 69.33 |
TPSA : | 55.56 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.85 cm/s |
Log Po/w (iLOGP) : | 2.68 |
Log Po/w (XLOGP3) : | 1.24 |
Log Po/w (WLOGP) : | 1.21 |
Log Po/w (MLOGP) : | 1.41 |
Log Po/w (SILICOS-IT) : | 1.25 |
Consensus Log Po/w : | 1.56 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.01 |
Solubility : | 2.32 mg/ml ; 0.00989 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.0 |
Solubility : | 2.32 mg/ml ; 0.00989 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.76 |
Solubility : | 0.408 mg/ml ; 0.00174 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.61 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With water; triphenylphosphine In tetrahydrofuran at 20℃; for 12 h; | General procedure: To a stirred soln of azide derivative 9a or 9b (4.03 mmol) in THF (1 mL) was added solid Ph3P (4.03 mmol) and H2O (6.04 mmol). The resulting solution was stirred for 12 h at r.t., then concentrated under reduced pressure. The crude product was purified by flash column chromatography on silica gel (MeOH–CH2Cl2, 9:1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74% | Stage #1: With borane In tetrahydrofuran at 0℃; for 7 h; Heating / reflux Stage #2: With hydrogenchloride; water In tetrahydrofuran at 0℃; for 6 h; Heating / reflux Stage #3: With sodium hydroxide In tetrahydrofuran; water |
A typical procedure for the reduction is as follows: starting with a solution of (S)-2-carbamoyl-l-7V-CBz-pyrrolidine (0.5g, 2mmol) in THF (10ml), borane BH3 (12ml, 12mmol, 1 .OM THF solution) was added slowly at 0°C under N2. The resulting solution was heated to reflux for 7 hours, then cooled to 0°C, followed by slow addition of 4.5mL of 12N HC1 to destroy the B-N complex. The mixture was heated to reflux for 6 hours, cooled to roomed temperature (RT), then was neutralized to ph8 by a WNaOH aqueous solution. After THF and water were removed under reduced pressure, the crude product was purified by use offlash silica gel column chromatography (1/10 = MeOH/CHzC^) to afford a clear, slightlyyellow oil in 74percent yield (348mg). |
[ 876461-55-1 ]
(S)-Benzyl 3-aminopiperidine-1-carboxylate
Similarity: 0.95
[ 1044560-96-4 ]
(R)-Benzyl 3-aminopiperidine-1-carboxylate
Similarity: 0.95
[ 960541-42-8 ]
Benzyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.94
[ 550378-39-7 ]
(S)-1-Cbz-3-Aminopyrrolidine hydrochloride
Similarity: 0.94
[ 876461-55-1 ]
(S)-Benzyl 3-aminopiperidine-1-carboxylate
Similarity: 0.95
[ 1044560-96-4 ]
(R)-Benzyl 3-aminopiperidine-1-carboxylate
Similarity: 0.95
[ 960541-42-8 ]
Benzyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.94
[ 550378-39-7 ]
(S)-1-Cbz-3-Aminopyrrolidine hydrochloride
Similarity: 0.94
[ 876461-55-1 ]
(S)-Benzyl 3-aminopiperidine-1-carboxylate
Similarity: 0.95
[ 1044560-96-4 ]
(R)-Benzyl 3-aminopiperidine-1-carboxylate
Similarity: 0.95
[ 960541-42-8 ]
Benzyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.94
[ 550378-39-7 ]
(S)-1-Cbz-3-Aminopyrrolidine hydrochloride
Similarity: 0.94
[ 876461-55-1 ]
(S)-Benzyl 3-aminopiperidine-1-carboxylate
Similarity: 0.95
[ 1044560-96-4 ]
(R)-Benzyl 3-aminopiperidine-1-carboxylate
Similarity: 0.95
[ 960541-42-8 ]
Benzyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.94
[ 550378-39-7 ]
(S)-1-Cbz-3-Aminopyrrolidine hydrochloride
Similarity: 0.94
[ 550378-39-7 ]
(S)-1-Cbz-3-Aminopyrrolidine hydrochloride
Similarity: 0.94
[ 870621-17-3 ]
(R)-1-Cbz-3-aminopyrrolidine Hydrochloride
Similarity: 0.94
[ 1279200-14-4 ]
(2R,4S)-Benzyl 4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate
Similarity: 0.92
[ 122536-75-8 ]
(R)-1-Cbz-3-Boc-Aminopyrrolidine
Similarity: 0.92
[ 1217652-74-8 ]
(R)-Benzyl (pyrrolidin-2-ylmethyl)carbamate hydrochloride
Similarity: 0.92